Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-19-028931

Chief Financial Officer sold 30,000 shares at $13.73 ($412,029)

  • Chief Financial Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Robb Gary Charles · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-09 Exercise or conversion : show line 1 in the form +30,000 $1.92 $57,600 38,025 D
2019-12-09 Sale : show line 2 in the form −30,000 $13.73 $412,029 8,025 D
Open-market sales · 30,000 sh · avg $13.73 · $412,029

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-09 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −30,000 45,000 D
Loading xslF345X03/doc4.xml…